This research project focuses on the identification of bioactive compounds derived from plants and the evaluation of their anticancer potential. The study investigates the cytotoxic effects of plant extracts, as well as pure natural compounds against a range of human cancer cell lines, including hepatic, breast, colon, and gastric cancer models. Particular emphasis is placed on elucidating the molecular mechanisms underlying their anticancer activity, such as the induction of apoptosis, cell cycle arrest, oxidative stress modulation, and the regulation of signaling pathways involved in tumor growth. In parallel, the project incorporates molecular diagnostic approaches to identify cancer-specific biomarkers and genetic alterations associated with disease progression and therapeutic response. By integrating natural product research with molecular oncology, this work aims to advance the development of novel anticancer agents and improve strategies for the molecular diagnosis and personalized management of cancer.
Key figures that reflect the laboratory’s activity, scientific output and contribution to research and education.